Today, the U.S. Food and Drug Administration (FDA) announced it has selected Apple, Fitbit, Johnson & Johnson, Pear Therapeutics, Phosphorus, Roche, Samsung, Tidepool and Google’s Verily to participate in the FDA’s new digital health per-certification pilot program. The FDA selected the final nine companies for the pre-cert pilot program based on several factors including company size, demonstrated record of quality and organizational excellence, clinical focus area and the risk profile of
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
